HER2 + BREAST CANCER
Clinical trials for HER2 + BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Shield drugs tested for breast cancer patients
Prevention OngoingThis study is testing if two common heart medications can prevent heart damage in people receiving a specific type of breast cancer treatment. It involves a small group of patients with HER2-positive breast cancer who are starting or recently started their cancer therapy. The goa…
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
Blood test could guide when to stop breast cancer treatment
Knowledge-focused OngoingThis study is testing a personalized blood test to see if it can detect tiny traces of cancer in patients with advanced HER2-positive breast cancer who have responded very well to treatment for over two years. The goal is to gather knowledge that might help doctors decide if and …
Matched conditions: HER2 + BREAST CANCER
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC